Conversion from Standard Opioid Therapy to Once-daily Oral Extended-release Hydromorphone in Patients with Chronic Cancer Pain

By Wallace M   Rauck RL   Moulin D   Thipphawong J   Khanna S   Tudor IC  

The Journal of International Medical Research, Vol. 36, Iss. 2, 2008-03 ,pp. : 343-352

Field House Publishing

Access to resources Recommend Favorite

Pharmacokinetic profile of once-daily cyclobenzaprine extended-release

By Darwish Mona   Hellriegel Edward T  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1425-1436

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol: A Randomised, Controlled Study versus Twice-Daily Tramadol in Patients with Osteoarthritis of the Knee

By Gérald Mongin  

Clinical Drug Investigation, Vol. 24, Iss. 9, 2004-01 ,pp. : 545-558

Adis International

Access to resources Recommend Favorite

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease

By Perez Lloret Santiago   Rascol Olivier  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2221-2230

Informa Healthcare

Access to resources Recommend Favorite

Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 361-369

John Wiley & Sons Inc

Access to resources Recommend Favorite